Benitec Biopharma (BNTC) Q2 2026 Earnings Report

319 Followers

BNTC Q2 2026 EPS Results

Actual EPS-$0.26

Consensus EPS-$0.22

Beat/MissMissed by -$0.04

One Year Ago EPS-$0.33

Actual Revenue$0.00

Expected Revenue$0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ2 2026

Date02/12/2026

TimeBefore Open

Conference CallThursday, February 12, 2026

BNTC Upcoming Earnings

Benitec Biopharma's next earnings date is estimated for November 16, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 16, 2026	2027 (Q1)	-0.28 / -	-0.22	―
Sep 14, 2026	2026 (Q4)	-0.26 / -0.26	-0.405	35.80% (+0.15)
May 14, 2026	2026 (Q3)	-0.27 / -0.24	-0.24	0.00% (0.00)
Feb 12, 2026	2026 (Q2)	-0.22 / -0.26	-0.33	21.21% (+0.07)
Nov 14, 2025	2026 (Q1)	-0.45 / -0.22	-0.48	54.17% (+0.26)
Sep 22, 2025	2025 (Q4)	-0.31 / -0.41	1.04	-138.94% (-1.45)
May 14, 2025	2025 (Q3)	-0.35 / -0.24	-1.64	85.37% (+1.40)
Feb 14, 2025	2025 (Q2)	-0.78 / -0.33	-2.64	87.50% (+2.31)
Nov 14, 2024	2025 (Q1)	-0.55 / -0.48	-2.76	82.61% (+2.28)
Sep 26, 2024	2024 (Q4)	-0.49 / 1.04	-0.01	10500.00% (+1.05)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed